ENTAFARMA
ENTAFARMA, officially known as UAB ENTAFARMA, is a prominent player in the pharmaceutical industry, headquartered in Lithuania (LT). Founded in 2005, the company has established itself as a key provider of high-quality pharmaceutical products and services across the Baltic region and beyond. ENTAFARMA focuses on the development, manufacturing, and distribution of innovative medicines, particularly in the fields of oncology and chronic diseases. With a commitment to excellence, ENTAFARMA has achieved significant milestones, including the expansion of its product portfolio and strategic partnerships that enhance its market position. The company is recognised for its unique formulations and adherence to stringent quality standards, setting it apart in a competitive landscape. As a trusted name in pharmaceuticals, ENTAFARMA continues to contribute to healthcare advancements, ensuring patient access to effective treatments.
DitchCarbon Score
How does ENTAFARMA's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Maritime Transport industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
ENTAFARMA's score of 6 is higher than 87% of the industry. This can give you a sense of how well the company is doing compared to its peers.
ENTAFARMA's reported carbon emissions
ENTAFAFMA currently does not have available carbon emissions data for the most recent year, nor do they have specified reduction targets or climate pledges. Without specific emissions figures or commitments, it is challenging to assess their carbon footprint or climate strategy. However, the absence of data may indicate a need for enhanced transparency and accountability in their environmental practices. As the industry increasingly prioritises sustainability, ENTAFARMA may benefit from establishing clear climate commitments and measurable reduction targets to align with global climate goals.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
ENTAFARMA is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
